Literature DB >> 22264161

High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.

Te Liu1, Gang Zou, Yongtao Gao, Xinrong Zhao, Hui Wang, Qin Huang, Lizhen Jiang, Lihe Guo, Weiwei Cheng.   

Abstract

Although many techniques can be used to generate multitype-induced pluripotent stem (iPS) cells from multitype seed cells, improving the efficiency and shortening the period of cell reprogramming remain troublesome issues. In this study, to generate iPS cells, CD34⁺ cells, isolated from human amniotic fluid cells (HuAFCs) by flow cytometry, were infected with retroviruses carrying only one reprogramming factor (Oct4) and cultured on human amniotic epithelial cell (HuAEC) feeder layers. Approximately 4 to 5 days after viral infection, some embryonic stem cell (ESC)-like colonies appeared among the feeder cells. These colonies were positive for alkaline phosphatase and expressed high levels of ESC pluripotent markers (Nanog, Sox2, Oct4, CD133, and Rex1). Moreover, these iPS cells exhibited high levels of telomerase activity and had normal karyotypes. Additionally, these cells could differentiate into cell types from all 3 germ layers in vivo and in teratomas. In summary, we report a novel way of iPS generation that uses CD34⁺ HuAFCs as seed cells. Using this method, we can generate human iPS cells with greater efficiency and safety (the oncogenic factors, c-Myc and Klf4, were not used), and using the minimum number of reprogramming factors (only one factor, Oct4). Besides, HuAECs were used as feeder layers to culture human iPS cells, which could not only avoid contamination with heterogeneous proteins, but also maintain iPS cells in a self-renewing and undifferentiated state for a long time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264161     DOI: 10.1089/scd.2011.0715

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  33 in total

Review 1.  Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).

Authors:  Valentina Spinelli; Pascale V Guillot; Paolo De Coppi
Journal:  Organogenesis       Date:  2013-04-01       Impact factor: 2.500

Review 2.  Application of Induced Pluripotent Stem Cells in Liver Diseases.

Authors:  Yue Yu; Xuehao Wang; Scott L Nyberg
Journal:  Cell Med       Date:  2014-04-22

Review 3.  iPSC modeling of rare pediatric disorders.

Authors:  Bethany A Freel; Jordan N Sheets; Kevin R Francis
Journal:  J Neurosci Methods       Date:  2019-12-04       Impact factor: 2.390

4.  MicroRNA-122 influences the development of sperm abnormalities from human induced pluripotent stem cells by regulating TNP2 expression.

Authors:  Te Liu; Yongyi Huang; Jianjun Liu; Yanhui Zhao; Lizhen Jiang; Qin Huang; Weiwei Cheng; Lihe Guo
Journal:  Stem Cells Dev       Date:  2013-03-06       Impact factor: 3.272

Review 5.  New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells.

Authors:  Zita Garate; Brian R Davis; Oscar Quintana-Bustamante; Jose C Segovia
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695

Review 6.  Congenital anomalies: treatment options based on amniotic fluid-derived stem cells.

Authors:  Shaun M Kunisaki
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

Review 7.  Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.

Authors:  Pratik A Lalit; Derek J Hei; Amish N Raval; Timothy J Kamp
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

8.  Induction of estrogen-sensitive epithelial cells derived from human-induced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure.

Authors:  Te Liu; Wenxing Qin; Yongyi Huang; Yanhui Zhao; Jiejun Wang
Journal:  DNA Cell Biol       Date:  2013-09-14       Impact factor: 3.311

9.  The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System.

Authors:  Enrica Bertin; Martina Piccoli; Chiara Franzin; Andras Nagy; Maria Mileikovsky; Paolo De Coppi; Michela Pozzobon
Journal:  J Vis Exp       Date:  2017-02-28       Impact factor: 1.355

10.  Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.

Authors:  Kate E Hawkins; Dafni Moschidou; Danilo Faccenda; Wasco Wruck; Alex Martin-Trujillo; Kwan-Leong Hau; Anna Maria Ranzoni; Veronica Sanchez-Freire; Fabio Tommasini; Simon Eaton; Paolo De Coppi; David Monk; Michelangelo Campanella; Adrian J Thrasher; James Adjaye; Pascale V Guillot
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.